Suppr超能文献

考虑最佳二次剂量的复发性或难治性三叉神经痛的伽玛刀放射外科重复治疗

Repeat Gamma-Knife Radiosurgery for Refractory or Recurrent Trigeminal Neuralgia with Consideration About the Optimal Second Dose.

作者信息

Park Seong-Cheol, Kwon Do Hoon, Lee Do Hee, Lee Jung Kyo

机构信息

Department of Neurosurgery, Asan Medical Center, Seoul, Korea.

Department of Neurosurgery, Asan Medical Center, Seoul, Korea; Department of Neurosurgery, College of Medicine, University of Ulsan, Seoul, Korea.

出版信息

World Neurosurg. 2016 Feb;86:371-83. doi: 10.1016/j.wneu.2015.08.056. Epub 2015 Sep 2.

Abstract

OBJECTIVE

To investigate adequate radiation doses for repeat Gamma Knife radiosurgery (GKS) for trigeminal neuralgia in our series and meta-analysis.

METHODS

Fourteen patients treated by ipsilateral repeat GKS for trigeminal neuralgia were included. Median age of patients was 65 years (range, 28-78), the median target dose, 140-180). Patients were followed a median of 10.8 months (range, 1-151) after the second gamma-knife surgery. Brainstem dose analysis and vote-counting meta-analysis of 19 studies were performed.

RESULTS

After the second gamma-knife radiosurgeries, pain was relieved effectively in 12 patients (86%; Barrow Neurological Institute Pain Intensity Score I-III). Post-gamma-knife radiosurgery trigeminal nerve deficits were mild in 5 patients. No serious anesthesia dolorosa was occurred. The second GKS radiation dose ≤ 60 Gy was significantly associated with worse pain control outcome (P = 0.018 in our series, permutation analysis of variance, and P = 0.009 in the meta-analysis, 2-tailed Fisher's exact test). Cumulative dose ≤ 140-150 Gy was significantly associated with poor pain control outcome (P = 0.033 in our series and P = 0.013 in the meta-analysis, 2-tailed Fisher's exact test). A cumulative brainstem edge dose >12 Gy tended to be associated with trigeminal nerve deficit (P = 0.077).

CONCLUSION

Our study suggests that the second GKS dose is a potentially important factor.

摘要

目的

在我们的系列研究和荟萃分析中,探讨三叉神经痛患者进行伽玛刀再次放射外科手术(GKS)的合适辐射剂量。

方法

纳入14例接受同侧三叉神经痛再次GKS治疗的患者。患者的中位年龄为65岁(范围28 - 78岁),中位靶剂量为140 - 180 。第二次伽玛刀手术后,患者的中位随访时间为10.8个月(范围1 - 151个月)。对19项研究进行了脑干剂量分析和投票计数荟萃分析。

结果

第二次伽玛刀放射外科手术后,12例患者(86%;巴罗神经学研究所疼痛强度评分I - III级)的疼痛得到有效缓解。5例患者伽玛刀放射外科手术后三叉神经功能缺损较轻。未发生严重的痛性麻木。第二次GKS辐射剂量≤60 Gy与较差的疼痛控制结果显著相关(在我们的系列研究中P = 0.018,方差置换分析,在荟萃分析中P = 0.009,双侧Fisher精确检验)。累积剂量≤140 - 150 Gy与较差的疼痛控制结果显著相关(在我们的系列研究中P = 0.033,在荟萃分析中P = 0.013,双侧Fisher精确检验)。累积脑干边缘剂量>12 Gy倾向于与三叉神经功能缺损相关(P = 0.077)。

结论

我们的研究表明,第二次GKS剂量是一个潜在的重要因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验